AstraZeneca 'magic' faces rare test after trial failure, share slide - Reuters
AstraZeneca 'magic' faces rare test after trial failure, share slide Reuters
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Key People
No people linked to this story
Locations
All Coverage
<a href="https://news.google.com/rss/articles/CBMi0wFBVV95cUxPR0g4ZlpxNDdMMDVHcV9Ka1BjMTJRZkFPVkQ0eGxUaXJzSmJQU2NEM2pLX3Y4bERtcTg4M2tjemFvYWtuWlZvdzhRRGlPMThvY2JMU1h3UkR4b3VQUEZaaEFEbkFEb3k0aTN6ajloU3hkLXpYUFVJQ0o5RDVOeE03UUhCSnBmMkJOSC01VUwyOG5yT0NpMmVBRk02NkNRMnhCajlYb0RYb0k2RVI4bmVwNzNXWnhFMkxqYU54SEdCQUZGcnZvV3NFaVRRTS1MR0tIZXk4?oc=5" target="_blank">AstraZeneca 'magic' faces rare test after trial failure, share slide</a> <font color="#6f6f6f">Reuters</font>
Similar Stories
Related coverage based on topic and tags
Four signs it is about to get uglier in the bond market as yields rise - Reuters
Four signs it is about to get uglier in the bond market as yields rise Reuters
October 9, 2026 at 04:18 PMBASF considers raising offer for Evonik, sources say - Reuters
BASF considers raising offer for Evonik, sources say Reuters
October 9, 2026 at 02:02 PMUS 10-year Treasury yield risks hitting 6% for first time since 2000, Pimco's Ivascyn tells FT - Reuters
US 10-year Treasury yield risks hitting 6% for first time since 2000, Pimco's Ivascyn tells FT Reuters
October 9, 2026 at 05:27 AMMorning Bid: Feeding the AI beast - Reuters
Morning Bid: Feeding the AI beast Reuters
October 9, 2026 at 04:31 AMGold rises more than 1%, Fed outlook in focus - Reuters
Gold rises more than 1%, Fed outlook in focus Reuters
October 9, 2026 at 01:58 AMArgenx discontinues Vyvgart study in Sjögren's disease, shares tumble - Reuters
Argenx discontinues Vyvgart study in Sjögren's disease, shares tumble Reuters
October 8, 2026 at 08:49 PM